Evening Sessions: Open to Public

Thursday, June 28

8:00 – 9:00 PM- Charles R. Cantor, Chief Scientific Officer and member, Board of Directors, Sequenom, Inc., San Diego, CA, and a member of the National Academy of Sciences. After the Human Genome.

9:15 – 10:15 – Debu Tripathy, UCSF Carol Franc Buck Breast Care Center
University of California at San Francisco, CA. Oncogene-Targeted Therapy for Cancer Comes of Age.

Friday, June 29

8:00 – 9:00 – Kenneth Lundstrom, Ph.D., Scientific Specialist, Preclinical Research,
F. Hoffmann-Roche Ltd., Basel, Switzerland Alphavirus vectors as tools in cancer therapy

Click to continue